Advertisement

Topics

UMS AG i.L. Reports on the First Nine Months of Fiscal Year 2017 / 2018

06:00 EDT 14 Mar 2018 | EQS Group

DGAP-News: UMS United Medical Systems International AG / Key word(s): 9-month figures/9-month figures

14.03.2018 / 10:00
The issuer is solely responsible for the content of this announcement.


UMS AG Reports on the First Nine Months of Fiscal Year 2017 / 2018

Hamburg, March 14,2018: UMS United Medical Systems International AG i.L. (UMS, ISIN DE 0005493654 / WKN 549365) has reported on the first nine months of the liquidation year. The expenses incurred were covered by the liquidation provision.

As a result, earnings per share amounted to EUR 0.00, just as in the same period of the previous year, while credit balances at banks fell as planned by EUR 333 thousand or EUR 8 cents per share and now amount to EUR 1,429 thousand or EUR 33 cents per share. As at the beginning of the liquidation period, shareholders' equity amounts to EUR 2,418 thousand or EUR 56 cents per share.

On February 15th the tax office decided on our objection in the special tax audit. Accordingly, the competent legal aid office has given us full redress and finally refunded EUR 1.3 million of input tax paid or not refunded plus interest. An important part of the liquidation has thus been successfully completed.

The proceedings against the company's former tax consultant, Ebner Stolz Wirtschaftsprüfer, Steuerberater, Rechtsanwälte, will now determine how long the liquidation period lasts. In its judgment of 23 May 2017, the Hamburg Court of Appeals ruled in full that the company was also entitled to sue Ebner Stolz in the second instance and ordered Ebner Stolz to pay damages for the harm suffered and to bear all costs of the proceedings. An appeal to the Federal Supreme Court was not allowed. Ebner Stolz filed a complaint against the decision of the Court of Appeals with the Federal Supreme Court, which has been discussed by the Federal Supreme Court since March 8, 2018. We expect a decision in our favor in April of this year.

The full report for the first nine months is available on the Company's website at www.umsag.com

The Company in Brief

UMS International AG is a stock corporation listed in the Prime Standard of Deutsche Börse AG. On August 14,2014, the Company sold its interest in United Medical Systems (DE), Inc. and thus sold its entire assets. The Company's Extraordinary General Meeting on September 25, 2014 approved the transfer of assets and liabilities. The agreement was finalized on November 11, 2014. Upon completion of the transfer of assets, the company's corporate purpose was changed to the management of its own assets.

At their annual meeting on April 27,2015, the shareholders resolved to dissolve the company on April 30, 2015.

Contact

Christian Möller, Tel: (040) 50 01 77-00, Fax: (040) 50 01 77-77, E-Mail:
investor@umsag.com



14.03.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

Original Article: UMS AG i.L. Reports on the First Nine Months of Fiscal Year 2017 / 2018

NEXT ARTICLE

More From BioPortfolio on "UMS AG i.L. Reports on the First Nine Months of Fiscal Year 2017 / 2018"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...